Hypertension and Hormone Mechanisms (eBook)
XII, 378 Seiten
Humana Press (Verlag)
978-1-59259-987-5 (ISBN)
This book reviews novel developments in the endocrinology of hypertension with emphasis on new discovery during the past five years and perspectives on the future. It is written by authors who have spearheaded recent advances. With a focus on new developments in hormones and autacoids related to hypertension, the book provides a resource that will lead to new, active research in the fundamental mechanisms of hypertension.
Hypertension and Hormone Mechanisms reviews novel developments in the endocrinology of hypertension with emphasis on new discovery during the past five years and perspectives on the future. Written by authors who have spearheaded recent advances, chapters cover innovations in our understanding of the reninangiotensin-aldosterone, the sympathoadrenal, and the renal dopaminergic systems. World-renowed researchers also discuss natriuretic peptides, vasoactive substances and vasopeptidases, insulin, free fatty acids, and the insulin resistance syndrome, sex hormones, and the vasculature and selected areas of diagnosis and therapy.With a focus on new developments in hormones and autacoids related to hypertension, Hypertension and Hormone Mechanisms provides a resource that will lead to new, active research in the fundamental mechanisms of hypertension.
Hypertension and Hormonal Mechanisms
Chapter Outline
(A) New Developments in the Renin-Angiotensin System
1. The Intrarenal Renal-Angiotensin System
Minolfa C. Prieto-Carrasquero, Hiroyuki Kobori and L. Gabriel Navar
Tulane University
2. Cardiac and Vascular Renin-Angiotensin Systems
Rajesh Kumar, Kenneth M. Baker and Jing Pan
Texas A & M University Health System
3. Regulation of Cardiovascular Control Mechanisms by Angiotensin (1-7)
and Angiotensin Converting Enzyme-2
Carlos M. Ferrario, David B. Averill, K. Bridget Brosnihan, Mark C. Chappell, Debra I. Diz, Patriciai E. Gallagher, Liomar A.A. Neves and E. Ann Tallant
Wake Forest University
4. Angiotensin IV and the AT4 Receptor
T. A. Jenkins, F.A.O. Mendelsohn, A.L. Albiston and S.Y. Chai
Howard Florey Institute of Experimental Physiology and Medicine, Melbourne
5. AT2 Receptors in Blood Pressure Regulation
Robert M. Carey and Helmy M. Siragy
University of Virginia Health System
6. Angiotensin II and Inflammation
Rhian M. Touyz and Ernesto L. Schiffrin
Clinical Research Institute of Montreal
7. Aldosterone and Vascular Damage
Hilton V. Joffe, Gordon H. Williams and Gail K. Adler
Harvard Medical School
(B) The Sympatho-Adrenal System in Hypertension
8. Neurogenic Human Hypertension
David Robertson, Andre Diedrich and Italo Biaggioni
Vanderbilt University
9. Calcitonin Gene-Related Peptide and Hypertension
Donald J. DiPette and Scott C. Supowit
Texas A& M University
10. The Renal Dopaminergic System in Hypertension
Pedro A. Jose, Robert M. Carey and Robin A. Felder
Georgetown University and the University of Virginia Health
System
(C) Metabolic Disorders and Hypertension
11. The Insulin Resistance Syndrome and Hypertension
James R. Sowers
University of Missouri
12. Fatty Acids and Hypertension
Brent M. Egan
Medical University of South Carolina
13. Goal-Oriented Hypertension Management in Diabetic and Non-Diabetic
Patients
Gregory M. Singer, John F. Setaro and Henry R. Black
Rush Presbyterian - St. Luke's Medical Cente
(D) Endothelial Hormones and Autacoids and Hypertension
14. Nitric Oxide and Hypertension
David L. Mattson and Allen W. Cowley
Medical College of Wisconsin
15. Role of Endothelin 1 in Hypertension
Ernesto L. Schiffrin
Clinical Research Institute of Montreal
16. The Kallekrein/Kinin System and Hypertension
Julie Chao and Lee Chao
Medical University of South Carolina
(E) Other Hormonal Systems and Hypertension
17. Natriuretic Peptides and Hypertension
Kailesh N. Pandey
Tulane University
18. Sex Steroids and Hypertension
Suzanne Oparil and Andrew Miller
University of Alabama Birmingham
19. The Lipoxygenase System in the Vasculature and Hypertension
Naftali Stern and Michael Tuck
Tel Aviv University and UCLA School of Medicine
| Erscheint lt. Verlag | 21.6.2010 |
|---|---|
| Reihe/Serie | Contemporary Endocrinology |
| Zusatzinfo | XII, 378 p. |
| Verlagsort | Totowa |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie |
| Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie | |
| Schlagworte | Aldosterone • Angiotensin II • Cardiovascular • cardiovascular control • Hypertension • Insulin • insulin resistance • Steroids |
| ISBN-10 | 1-59259-987-7 / 1592599877 |
| ISBN-13 | 978-1-59259-987-5 / 9781592599875 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 6,1 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
